Israel Discount Bank Of New York Abb Vie Inc. Transaction History

Israel Discount Bank Of New York

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $10,446 - $13,352	-159 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $1,557 - $1,920	20 Added 14.39%	159 $15,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $1,778 - $1,976	-20 Reduced 12.58%	139 $13,000
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $8,956 - $9,821	-100 Reduced 38.61%	159 $15,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $18,091 - $23,107	259	259 $23,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Israel Discount Bank Of New York, based on Form 13F filings with the SEC.

Stay updated on Israel Discount Bank Of New York with notifications on news.